Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia

Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, leading to significant morbidity and mortality. The objective of this work is to describe a series...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Mahwash, Vora, Amy, Ali, Sadia, Abramowitz, Jessica, Mirfakhraee, Sasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692539/
https://www.ncbi.nlm.nih.gov/pubmed/33294765
http://dx.doi.org/10.1210/jendso/bvaa171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692539/
https://www.ncbi.nlm.nih.gov/pubmed/33294765
http://dx.doi.org/10.1210/jendso/bvaa171

Ejemplares similares